Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
July 26, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
July 13, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
July 10, 2023 07:30 ET
|
Incannex Healthcare
Highlights: Incannex to redomicile to the United States via a Scheme of Arrangement pursuant to Australian lawA newly formed Delaware corporation (Incannex Healthcare Inc.) will become the ultimate...
Incannex Announces Participation at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference June 26, 2023
June 23, 2023 08:00 ET
|
Incannex Healthcare
MELBOURNE, Australia, June 23, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal cannabinoid...
Beckley Waves Establishes Ethics Council to Guide Industry Standards and Best Practices During Inaugural Summit of The World’s Leaders in Psychedelics
June 01, 2023 09:00 ET
|
Beckley Waves
The New Ethics Council will Work Alongside Beckley Waves to set the Standard for Sustainable and Ethical Operations in the Burgeoning Psychedelics Sector Experts Involved in the Council Include Paul...
World Renowned International Psychedelics Experts Join Clarion Clinics Advisory Board
May 30, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Three world-leading clinical psychedelics experts join Clarion Clinics Advisory Board.Dr. Bill Richards is among the world’s best known psychedelic researchers and practitioners. He has...
Psychedelic-Assisted Therapies Allowed in Australia Through Special Access Scheme
February 03, 2023 18:40 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
SAN JOSE, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) -- The Therapeutic Goods Administration (TGA) in Australia announced today that they will permit limited use of certain psychedelic-assisted...
Alchemy Community Therapy Center Welcomes New Board Members
December 13, 2022 11:00 ET
|
Alchemy Community Therapy Center
OAKLAND, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- The Alchemy Community Therapy Center, a 501(c)(3) non-profit which provides high-quality training and accessible psychedelic therapy to underserved...
Leading Oakland Psychedelic Therapy Clinic Announces New Name
November 15, 2022 14:35 ET
|
Alchemy Community Therapy Center
OAKLAND, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Sage Institute for Psychedelic Therapy, a 501(c) 3 non-profit which provides high-quality training and accessible psychedelic therapy to...
Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health
October 06, 2022 12:51 ET
|
Optimi Health Corp.
Highlights: The safe supply of psychedelic drug products manufactured at a GMP-level is critical in treating serious mental health issues. Minister of Mental Health and Addictions, the Honourable...